GPFT - Grapefruit USA Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Grapefruit USA Inc.

10866 Wilshire Boulevard
Suite 225
Los Angeles, CA 90024
United States
310-205-1382
http://www.grapefruitblvd.com

SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees14

Key Executives

NameTitlePayExercisedYear Born
Mr. Bradley J. YouristCEO, Pres & Board ChairmanN/AN/A1969
Mr. Daniel J. YouristCOO, Corp. Sec. & DirectorN/AN/A1968
Beth JonesChief Compliance OfficerN/AN/AN/A
Chantel LeeHead of Sales & MarketingN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Grapefruit USA Inc. focuses on the manufacture and distribution of cannabis products in the United States. It provides cannabis distillates and edibles. The company was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA Inc. in January 2020. Grapefruit USA Inc. was founded in 2017 and is based in Los Angeles, California. Grapefruit USA Inc. is a subsidiary of Imaging3, Inc.

Corporate Governance

Grapefruit USA Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.